Covid-19 Therapeutic Market Report

China Covid-19 Therapeutic Industry Market Research Report 2023-2029

  • POSTDATE：Sep 21, 2023
  • PAGES：155
  • REPORT CODE：GMM1812598
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Covid-19 Therapeutic industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • AbbVie

    • GlaxoSmithKline

    • Roche

    • Cadila Healthcare

    • Pfizer

    • Ascletis Pharma

    • Sanofi

    • Novartis

    • Johnson & Johnson

    • Cipla

    • AstraZeneca

    • Zhejiang Hisun Pharmaceutical Co Ltd

    • Fujifilm Holdings

    • ImmunoPrecise

    • Gilead Sciences

    By Type:

    • Others

    • Antiviral Medicine

    • Plasma Therapy

    • Life Support

    • Immunotherapy

    By Application:

    • Adult

    • Children

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Covid-19 Therapeutic Market Overview 2018-2029

    • 1.1 China Covid-19 Therapeutic Industry Development Overview

    • 1.2 China Covid-19 Therapeutic Industry Development History

    • 1.3 China Covid-19 Therapeutic Industry Market Size (2018-2029)

    • 1.4 China Covid-19 Therapeutic Market Analysis by Type from Production Side

      • 1.4.1 China Covid-19 Therapeutic Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.2 China Covid-19 Therapeutic Production Volume, Production Value and Growth Rate of Antiviral Medicine (2018-2029)

      • 1.4.3 China Covid-19 Therapeutic Production Volume, Production Value and Growth Rate of Plasma Therapy (2018-2029)

      • 1.4.4 China Covid-19 Therapeutic Production Volume, Production Value and Growth Rate of Life Support (2018-2029)

      • 1.4.5 China Covid-19 Therapeutic Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)

    • 1.5 China Covid-19 Therapeutic Market Analysis by Application from Consumption End

      • 1.5.1 China Covid-19 Therapeutic Sales Volume, Sales Value and Growth Rate of Adult (2018-2029)

      • 1.5.2 China Covid-19 Therapeutic Sales Volume, Sales Value and Growth Rate of Children (2018-2029)

    • 1.6 China Covid-19 Therapeutic Market Analysis by Region

      • 1.6.1 North China Covid-19 Therapeutic Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Covid-19 Therapeutic Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Covid-19 Therapeutic Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Covid-19 Therapeutic Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Covid-19 Therapeutic Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Covid-19 Therapeutic Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Covid-19 Therapeutic Market Size and Growth Rate from 2018-2029

    Chapter 2 China Covid-19 Therapeutic Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Covid-19 Therapeutic Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Covid-19 Therapeutic Market Status and Competition Analysis in 2023

      • 2.2.3 China Covid-19 Therapeutic Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Covid-19 Therapeutic Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Covid-19 Therapeutic Industry Development

    Chapter 3 Covid-19 TherapeuticIndustry Chain Analysis

    • 3.1 Covid-19 Therapeutic Industry Chain

    • 3.2 Covid-19 Therapeutic Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Covid-19 Therapeutic Market

    • 3.3 Covid-19 Therapeutic Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Covid-19 Therapeutic Market

    Chapter 4 China Covid-19 Therapeutic Market, by Type

    • 4.1 China Covid-19 Therapeutic Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Covid-19 Therapeutic Total Production Volume and Growth Rate from Production Side

    • 4.5 China Covid-19 Therapeutic Production Volume and Growth Rate, by Type

      • 4.5.1 China Covid-19 Therapeutic Production Volume and Growth Rate of Others

      • 4.5.2 China Covid-19 Therapeutic Production Volume and Growth Rate of Antiviral Medicine

      • 4.5.3 China Covid-19 Therapeutic Production Volume and Growth Rate of Plasma Therapy

      • 4.5.4 China Covid-19 Therapeutic Production Volume and Growth Rate of Life Support

      • 4.5.5 China Covid-19 Therapeutic Production Volume and Growth Rate of Immunotherapy

    Chapter 5 China Covid-19 Therapeutic Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Covid-19 Therapeutic Total Market Size and Growth Rate from Consumption End

    • 5.5 China Covid-19 Therapeutic Market Size and Growth Rate, by Application

      • 5.5.1 China Covid-19 Therapeutic Market Size and Growth Rate of Adult

      • 5.5.2 China Covid-19 Therapeutic Market Size and Growth Rate of Children

    Chapter 6 China Covid-19 Therapeutic Market, by Region

    • 6.1 China Covid-19 Therapeutic Production Volume and Production Value, by Region

    • 6.2 China Covid-19 Therapeutic Sales Volume and Sales Value, by Region

    Chapter 7 North China Covid-19 Therapeutic Market Analysis

    • 7.1 North China Covid-19 Therapeutic Market, by Type

    • 7.2 North China Covid-19 Therapeutic Market, by Application

    Chapter 8 Central China Covid-19 Therapeutic Market Analysis

    • 8.1 Central China Covid-19 Therapeutic Market, by Type

    • 8.2 Central China Covid-19 Therapeutic Market, by Application

    Chapter 9 South China Covid-19 Therapeutic Market Analysis

    • 9.1 South China Covid-19 Therapeutic Market, by Type

    • 9.2 South China Covid-19 Therapeutic Market, by Application

    Chapter 10 East China Covid-19 Therapeutic Market Analysis

    • 10.1 East China Covid-19 Therapeutic Market, by Type

    • 10.2 East China Covid-19 Therapeutic Market, by Application

    Chapter 11 Northeast China Covid-19 Therapeutic Market Analysis

    • 11.1 Northeast China Covid-19 Therapeutic Market, by Type

    • 11.2 Northeast China Covid-19 Therapeutic Market, by Application

    Chapter 12 Southwest China Covid-19 Therapeutic Market Analysis

    • 12.1 Southwest China Covid-19 Therapeutic Market, by Type

    • 12.2 Southwest China Covid-19 Therapeutic Market, by Application

    Chapter 13 Northwest China Covid-19 Therapeutic Market Analysis

    • 13.1 Northwest China Covid-19 Therapeutic Market, by Type

    • 13.2 Northwest China Covid-19 Therapeutic Market, by Application

    Chapter 14 Company Profiles

      • 14.1 AbbVie

        • 14.1.1 AbbVie Company Profile

        • 14.1.2 AbbVie Covid-19 Therapeutic Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 GlaxoSmithKline

        • 14.2.1 GlaxoSmithKline Company Profile

        • 14.2.2 GlaxoSmithKline Covid-19 Therapeutic Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Roche

        • 14.3.1 Roche Company Profile

        • 14.3.2 Roche Covid-19 Therapeutic Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Cadila Healthcare

        • 14.4.1 Cadila Healthcare Company Profile

        • 14.4.2 Cadila Healthcare Covid-19 Therapeutic Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Pfizer

        • 14.5.1 Pfizer Company Profile

        • 14.5.2 Pfizer Covid-19 Therapeutic Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Ascletis Pharma

        • 14.6.1 Ascletis Pharma Company Profile

        • 14.6.2 Ascletis Pharma Covid-19 Therapeutic Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Sanofi

        • 14.7.1 Sanofi Company Profile

        • 14.7.2 Sanofi Covid-19 Therapeutic Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Novartis

        • 14.8.1 Novartis Company Profile

        • 14.8.2 Novartis Covid-19 Therapeutic Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Johnson & Johnson

        • 14.9.1 Johnson & Johnson Company Profile

        • 14.9.2 Johnson & Johnson Covid-19 Therapeutic Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Cipla

        • 14.10.1 Cipla Company Profile

        • 14.10.2 Cipla Covid-19 Therapeutic Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 AstraZeneca

        • 14.11.1 AstraZeneca Company Profile

        • 14.11.2 AstraZeneca Covid-19 Therapeutic Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Zhejiang Hisun Pharmaceutical Co Ltd

        • 14.12.1 Zhejiang Hisun Pharmaceutical Co Ltd Company Profile

        • 14.12.2 Zhejiang Hisun Pharmaceutical Co Ltd Covid-19 Therapeutic Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Fujifilm Holdings

        • 14.13.1 Fujifilm Holdings Company Profile

        • 14.13.2 Fujifilm Holdings Covid-19 Therapeutic Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 ImmunoPrecise

        • 14.14.1 ImmunoPrecise Company Profile

        • 14.14.2 ImmunoPrecise Covid-19 Therapeutic Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Gilead Sciences

        • 14.15.1 Gilead Sciences Company Profile

        • 14.15.2 Gilead Sciences Covid-19 Therapeutic Market Performance

        • 14.15.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Covid-19 Therapeutic Industry Research Conclusions

    • 15.2 Covid-19 Therapeutic Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Covid-19 Therapeutic Industry Market Size (2018-2029)

    • Figure China Covid-19 Therapeutic Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Covid-19 Therapeutic Production Volume, Production Value and Growth Rate of Antiviral Medicine (2018-2029)

    • Figure China Covid-19 Therapeutic Production Volume, Production Value and Growth Rate of Plasma Therapy (2018-2029)

    • Figure China Covid-19 Therapeutic Production Volume, Production Value and Growth Rate of Life Support (2018-2029)

    • Figure China Covid-19 Therapeutic Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)

    • Figure China Covid-19 Therapeutic Sales Volume, Sales Value and Growth Rate of Adult (2018-2029)

    • Figure China Covid-19 Therapeutic Sales Volume, Sales Value and Growth Rate of Children (2018-2029)

    • Figure North China Covid-19 Therapeutic Market Size and Growth Rate from 2018-2029

    • Figure Central China Covid-19 Therapeutic Market Size and Growth Rate from 2018-2029

    • Figure South China Covid-19 Therapeutic Market Size and Growth Rate from 2018-2029

    • Figure East China Covid-19 Therapeutic Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Covid-19 Therapeutic Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Covid-19 Therapeutic Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Covid-19 Therapeutic Market Size and Growth Rate from 2018-2029

    • Figure Covid-19 Therapeutic Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Covid-19 Therapeutic Market Share by Type in 2018

    • Figure China Covid-19 Therapeutic Market Share by Type in 2023

    • Figure China Covid-19 Therapeutic Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Covid-19 Therapeutic Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Covid-19 Therapeutic Production Volume and Growth Rate of Antiviral Medicine (2018-2023)

    • Figure China Covid-19 Therapeutic Production Volume and Growth Rate of Plasma Therapy (2018-2023)

    • Figure China Covid-19 Therapeutic Production Volume and Growth Rate of Life Support (2018-2023)

    • Figure China Covid-19 Therapeutic Production Volume and Growth Rate of Immunotherapy (2018-2023)

    • Figure China Covid-19 Therapeutic Market Share by Application in 2018

    • Figure China Covid-19 Therapeutic Market Share by Application in 2023

    • Figure China Covid-19 Therapeutic Total Market Size and Growth Rate from Consumption End

    • Figure China Covid-19 Therapeutic Market Size and Growth Rate of Adult (2018-2023)

    • Figure China Covid-19 Therapeutic Market Size and Growth Rate of Children (2018-2023)

    • Table China Covid-19 Therapeutic Production Volume by Region (2018-2023)

    • Table China Covid-19 Therapeutic Production Volume Share by Region (2018-2023)

    • Figure China Covid-19 Therapeutic Production Volume Share by Region (2018-2023)

    • Table China Covid-19 Therapeutic Production Value by Region (2018-2023)

    • Table China Covid-19 Therapeutic Production Value Share by Region (2018-2023)

    • Figure China Covid-19 Therapeutic Production Value Share by Region (2018-2023)

    • Table China Covid-19 Therapeutic Sales Volume by Region (2018-2023)

    • Table China Covid-19 Therapeutic Sales Volume Share by Region (2018-2023)

    • Figure China Covid-19 Therapeutic Sales Volume Share by Region (2018-2023)

    • Table China Covid-19 Therapeutic Sales Value by Region (2018-2023)

    • Table China Covid-19 Therapeutic Sales Value Share by Region (2018-2023)

    • Figure China Covid-19 Therapeutic Sales Value Share by Region (2018-2023)

    • Table North China Covid-19 Therapeutic Production Volume by Type (2018-2023)

    • Table North China Covid-19 Therapeutic Production Volume Share by Type (2018-2023)

    • Figure North China Covid-19 Therapeutic Production Volume Share by Type (2018-2023)

    • Table North China Covid-19 Therapeutic Sales Volume by Application (2018-2023)

    • Table North China Covid-19 Therapeutic Sales Volume Share by Application (2018-2023)

    • Figure North China Covid-19 Therapeutic Sales Volume Share by Application (2018-2023)

    • Table Central China Covid-19 Therapeutic Production Volume by Type (2018-2023)

    • Table Central China Covid-19 Therapeutic Production Volume Share by Type (2018-2023)

    • Figure Central China Covid-19 Therapeutic Production Volume Share by Type (2018-2023)

    • Table Central China Covid-19 Therapeutic Sales Volume by Application (2018-2023)

    • Table Central China Covid-19 Therapeutic Sales Volume Share by Application (2018-2023)

    • Figure Central China Covid-19 Therapeutic Sales Volume Share by Application (2018-2023)

    • Table South China Covid-19 Therapeutic Production Volume by Type (2018-2023)

    • Table South China Covid-19 Therapeutic Production Volume Share by Type (2018-2023)

    • Figure South China Covid-19 Therapeutic Production Volume Share by Type (2018-2023)

    • Table South China Covid-19 Therapeutic Sales Volume by Application (2018-2023)

    • Table South China Covid-19 Therapeutic Sales Volume Share by Application (2018-2023)

    • Figure South China Covid-19 Therapeutic Sales Volume Share by Application (2018-2023)

    • Table East China Covid-19 Therapeutic Production Volume by Type (2018-2023)

    • Table East China Covid-19 Therapeutic Production Volume Share by Type (2018-2023)

    • Figure East China Covid-19 Therapeutic Production Volume Share by Type (2018-2023)

    • Table East China Covid-19 Therapeutic Sales Volume by Application (2018-2023)

    • Table East China Covid-19 Therapeutic Sales Volume Share by Application (2018-2023)

    • Figure East China Covid-19 Therapeutic Sales Volume Share by Application (2018-2023)

    • Table Northeast China Covid-19 Therapeutic Production Volume by Type (2018-2023)

    • Table Northeast China Covid-19 Therapeutic Production Volume Share by Type (2018-2023)

    • Figure Northeast China Covid-19 Therapeutic Production Volume Share by Type (2018-2023)

    • Table Northeast China Covid-19 Therapeutic Sales Volume by Application (2018-2023)

    • Table Northeast China Covid-19 Therapeutic Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Covid-19 Therapeutic Sales Volume Share by Application (2018-2023)

    • Table Southwest China Covid-19 Therapeutic Production Volume by Type (2018-2023)

    • Table Southwest China Covid-19 Therapeutic Production Volume Share by Type (2018-2023)

    • Figure Southwest China Covid-19 Therapeutic Production Volume Share by Type (2018-2023)

    • Table Southwest China Covid-19 Therapeutic Sales Volume by Application (2018-2023)

    • Table Southwest China Covid-19 Therapeutic Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Covid-19 Therapeutic Sales Volume Share by Application (2018-2023)

    • Table Northwest China Covid-19 Therapeutic Production Volume by Type (2018-2023)

    • Table Northwest China Covid-19 Therapeutic Production Volume Share by Type (2018-2023)

    • Figure Northwest China Covid-19 Therapeutic Production Volume Share by Type (2018-2023)

    • Table Northwest China Covid-19 Therapeutic Sales Volume by Application (2018-2023)

    • Table Northwest China Covid-19 Therapeutic Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Covid-19 Therapeutic Sales Volume Share by Application (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Covid-19 Therapeutic Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Covid-19 Therapeutic Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Covid-19 Therapeutic Revenue, Price and Gross (2018-2023)

    • Table Cadila Healthcare Company Profile

    • Table Cadila Healthcare Covid-19 Therapeutic Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Covid-19 Therapeutic Revenue, Price and Gross (2018-2023)

    • Table Ascletis Pharma Company Profile

    • Table Ascletis Pharma Covid-19 Therapeutic Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Covid-19 Therapeutic Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Covid-19 Therapeutic Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Covid-19 Therapeutic Revenue, Price and Gross (2018-2023)

    • Table Cipla Company Profile

    • Table Cipla Covid-19 Therapeutic Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Covid-19 Therapeutic Revenue, Price and Gross (2018-2023)

    • Table Zhejiang Hisun Pharmaceutical Co Ltd Company Profile

    • Table Zhejiang Hisun Pharmaceutical Co Ltd Covid-19 Therapeutic Revenue, Price and Gross (2018-2023)

    • Table Fujifilm Holdings Company Profile

    • Table Fujifilm Holdings Covid-19 Therapeutic Revenue, Price and Gross (2018-2023)

    • Table ImmunoPrecise Company Profile

    • Table ImmunoPrecise Covid-19 Therapeutic Revenue, Price and Gross (2018-2023)

    • Table Gilead Sciences Company Profile

    • Table Gilead Sciences Covid-19 Therapeutic Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US